UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
FORM 4
[ ] Check this box if no longer OMB APROVAL
subject to Section 16. Form 4 or OMB NUMBER: 3235-0287
Form 5 obligations may continue. Expires: September 30, 1998
See Instruction 1(b). Estimated average burden
hours per response........0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person*
Husain M. Fazle
- -----------------------------------------------------------------------------
(Last) (First) (Middle)
1221 Avenue of the Americas
- -----------------------------------------------------------------------------
(Street)
New York NY 10020
- -----------------------------------------------------------------------------
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Allscripts Healthcare Solutions, Inc. (MDRX)
- -----------------------------------------------------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
- -----------------------------------------------------------------------------
4. Statement for Month/Year
05/01
- -----------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Day/Year)
- -----------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
X Director 10% Owner
--- ---
Officer (give title below) Other (specify below)
--- ---
- ----------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
- ----
Form filed by More than One Reporting Person
- ----
Table I -- Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired 5. Amount of Securities 6. Ownership 7. Nature of
(Instr. 3) action action (A) or Disposed of Beneficially Owned Form: Direct Indirect
Date Code (D) (Instr. 3, 4 at End of Month (D) or In- Beneficial
(Instr.8) and 5) (Instr. 3 and 4) direct (I) Ownership
(Month/ (Instr. 4) (Instr. 4)
Day/ (A) or
Year) Code V Amount (D) Price
- ------------------------- --------- ---- --- ------- --- --------- -------------------- -------------- -------------
Common Stock 05/01/01 J(1) 18,930 A 0 18,930 D through
participation
Common Stock 3,954,063 I(1) through
partnerships
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
(Over)
SEC 1474 (7-96)
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of 2. Conversion or 3. Transaction Date 4. Transaction 5. Number of 6. Date Exercisable and
Derivative Exercise Price (Month/Day/Year) Code Derivative Expiration Date
Security of Derivative (Instr. 8) Securities (Month/Day/Year)
(Instr. 3) Security Acquired (A)
or Disposed of
(D) (Instr. 3,
4 and 5)
Date Expiration
Code V (A) (D) Exercisable Date
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of 7. Title and Amount of 8. Price of 9. Number of 10. Ownership 11. Nature of
Derivative Underlying Securities Derivative derivative Form of Indirect
Security (Instr. 3 and 4) Security Securities Derivative Beneficial
(Instr. 3) (Instr. 5) Beneficially Security: Ownership
Amount Owned at End Direct (D) (Instr. 4)
or of Month or Indirect
Number (Instr. 4) (I)
of (Instr. 4)
Title Shares
- ------------------------------------------------------------------------------------------------------------------------------------
- --------------------------------
Explanation of Responses:
1. The Reporting Person received 18,930 shares of Common Stock in a
distribution-in-kind from Morgan Stanley Venture Partners III, L.L.C., the /s/ Debra Abramovitz 06/08/01
general partner (the "General Partner") of Morgan Stanley Venture Partners ------------------------------- --------------
III, L.P., Morgan Stanley Venture Investors III, L.P., and The Morgan **Signature of Reporting Person Date
Stanley Venture Partners Entrepreneur Fund, L.P (collectively, the Debra Abramovitz, Attorney-in-
"Funds"). The General Partner had received the shares of Common Stock in Fact for M. Fazle Husain
distributions-in-kind from the Funds.
2. The Reporting Person is a managing member of the General Partner. The
Reporting Person disclaims any beneficial ownership of any of the
securities owned by the Funds except to the extent of his proportionate
pecuniary interest in the General Partner.
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained Page 2
in this form are not required to respond unless the form displays a currently SEC 1474 (7-96)
valid OMB Number.
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints Debra Abramovitz, the undersigned's true and lawful attorney-in-fact
to:
(1) execute for an on behalf of the undersigned, in the undersigned's
capacity as a director of Allscripts Healthcare Solutions, Inc. (the
"Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5 and timely file such form with the United States
Securities and Exchange Commission and stock exchange or similar
authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 8th day of June, 2001.
/s/ M. Fazle Husain
---------------------
Signature
M. Fazle Husain
---------------------
Print Name
2
